Predicting Length-of-Stay & Risk of Mortality for ICU Patients

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

Pangaea Named ‘Digital Solution of the Year’ by UK Government’s Department for International Trade

Global Pharmaceutical Proves Pangaea’s AI

Go back

UK Government Selects Pangaea to Showcase at BIO International Convention 2023

June 5th - 8th, 2023, Chicago, IL, USA

Visit Us at the UK Pavilion (#2348)

Venue: McCormick Place, Chicago, IL, USA

Learn about Pangaea’s novel AI-driven product platform to characterize patients by automatically discovering the clinical signatures (which clinicians ascertain manually) across 4,000 hard-to-diagnose conditions in an evolving, privacy-preserving and scalable manner. Pangaea has clinically proven to find 22x more undiagnosed, miscoded and at-risk patients; match 5x more patients to trials and therapies; discover new relationships between drugs, features and adverse events; predict prognosis; summarize patient records and automatically generate succinct human-readable clinical narratives for regulatory reports, saving 90 percent in enterprise costs and time. Pangaea’s knowledge-driven approach has helped improve patient outcomes and realize the true promise of preventative health and precision medicine through sustainable collaborations between healthcare and the pharmaceutical industry.

Please let us know if you are available to meet by registering through the link below or emailing us at

Schedule A Meeting


Dr. Vibhor Gupta
Director & Founder
Pangaea Data